Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Esperion Therapeutics Inc (ESPR)

Healthcare Drug Manufacturers - Specialty & Generic

3.20 $

+0.0% vs. previous close

Closing price · As of: 15. Jul 2026

Esperion Therapeutics Inc (ESPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 463 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet ESPR
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	235	221	206	373	352	314	344	324	347	364	466	463
Current Assets	232	218	201	366	345	308	338	319	343	360	168	459
Cash	138	115	82	227	189	145	145	115	86	92	168	156
Cash & Short-Term Investments	138	115	82	227	189	145	145	115	86	92	168	156
Receivables	41	43	48	55	60	68	80	81	108	119	140	132
Inventory	46	51	66	73	84	80	94	99	114	142	105	104
Property, Plant & Equipment	0.0	3.0	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Total Liabilities	607	631	661	667	697	684	733	750	781	815	768	770
Current Liabilities	107	138	156	165	175	166	246	271	299	359	301	300
Short-Term Debt	23	38	36	46	2.7	2.7	57	57	124	152	92	82
Accounts Payable	25	26	32	28	48	35	52	72	75	78	65	68
Long-Term Debt	261	261	262	262	262	263	238	238	243	249	249	250
Shareholders' Equity	-372	-410	-455	-294	-344	-370	-389	-426	-434	-451	-302	-308
Retained Earnings	-1,452	-1,493	-1,549	-1,488	-1,550	-1,580	-1,601	-1,641	-1,654	-1,686	-1,624	-1,649
Shares Outstanding	109	112	112	190	189	195	196	196	197	198	285	251

Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings